Purpose IncreasedsHER2 can be an signal of poor prognosisin HER2+ metastatic breasts cancer. Within Hands TCS 359 A B and C sufferers with baseline sHER2 ≥ 15ng/mL had been found to possess worse DFS than sufferers with baseline sHER2
Purpose IncreasedsHER2 can be an signal of poor prognosisin HER2+ metastatic breasts cancer. Within Hands TCS 359 A B and C sufferers with baseline sHER2 ≥ 15ng/mL had been found to possess worse DFS than sufferers with baseline sHER2